News - Biogen Idec, Financial

Filter

Current filters:

Biogen IdecFinancial

Popular Filters

1 to 25 of 1533 results

OxThera gains $10 million investment to continue Phase II trial

16-04-2014

Shareholders of privately-held Swedish biopharmaceutical company OxThera have agreed with a syndicate…

BiopharmaceuticalFinancialKidney diseasesOxTheraPharmaceuticalPrimary hyperoxaluriaRare diseasesRemi DrollerSweden

Johnson & Johnson 1st-qtr 2014 results beat expectations

Johnson & Johnson 1st-qtr 2014 results beat expectations

15-04-2014

US health care giant Johnson & Johnson today reported financial results for the first quarter of 2014,…

FinancialJohnson & JohnsonPharmaceutical

$5 million milestone for India’s Glenmark from Sanofi

15-04-2014

Indian drugmaker Glenmark Pharmaceuticals says it has informed the Stock Exchange that it has received…

FinancialGlenmark PharmaceuticalsInflammatory diseasesPharmaceuticalResearchSanofi

Boehringer Ingelheim posts 2013 financials with currency adjusted sales up 1.4%

Boehringer Ingelheim posts 2013 financials with currency adjusted sales up 1.4%

15-04-2014

German family-owned drug major Boehringer Ingelheim today posted financial results for 2013, noting that,…

Boehringer IngelheimFinancialPharmaceutical

Ukraine drug imports halted due to VAT confusion

Ukraine drug imports halted due to VAT confusion

15-04-2014

Imports of medicines into Ukraine have completely stopped, due to current confusions regarding the value-added…

Eastern EuropeFinancialMarkets & MarketingPharmaceuticalUkraine

Roche starts 2014 with sales dip due to strong franc

Roche starts 2014 with sales dip due to strong franc

15-04-2014

Swiss pharma major Roche kicked of the 2014 financial results reporting season, posting a 1% dip in group…

FinancialPharmaceuticalRoche

Total spending growth returns for US medicines, reports IMS Health

Total spending growth returns for US medicines, reports IMS Health

15-04-2014

Total spending on US medicines increased 1.0% on a real per capita basis in 2013, while the use of health…

FinancialHealthcareMarkets & MarketingNorth AmericaPharmaceuticalUSA

Negative results for asthma candidate cause Cytos Biotech to look at liquidation

14-04-2014

Swiss drug developer Cytos Biotechnology today revealed that the Phase IIb study of CYT003 in patients…

BiotechnologyFinancialResearchRespiratory and Pulmonary

Joint purchasing of vaccines and medicines becomes a reality in the EU

Joint purchasing of vaccines and medicines becomes a reality in the EU

10-04-2014

The European Commission today approved a Joint Procurement Agreement, which will enable all European…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceuticalVaccines

Positive Ph III pediatric data for investigational hemophilia A drug Eloctate

Positive Ph III pediatric data for investigational hemophilia A drug Eloctate

10-04-2014

US biotech firm Biogen Idec and Swedish Orphan Biovitrum today released positive top-line results of…

Biogen IdecEloctateHematologyResearchSwedish Orphan Biovitrum

Australia to review program for life-saving drugs access

Australia to review program for life-saving drugs access

10-04-2014

The Australian government says that it will review the Life Saving Drugs Program (LSDP) - a move aimed…

Asia-PacificAustraliaFinancialHealthcarePharmaceuticalRare diseases

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda

Seattle Genetics earns $6 million milestone under Adcetris accord with Takeda

08-04-2014

US biotech firm Seattle Genetics says it will receive milestone payments from Japan’s Takeda Pharmaceutical…

AdcetrisAsia-PacificBiotechnologyFinancialMarkets & MarketingOncologySeattle GeneticsSouth AmericaTakeda Pharmaceuticals

Promoting competition key to improving patients’ access to high cost medicines, says PHARMAC

Promoting competition key to improving patients’ access to high cost medicines, says PHARMAC

08-04-2014

New Zealand’s Pharmaceutical Management Agency, PHARMAC, has announced its intention to test out a…

Asia-PacificFinancialHealthcareNew ZealandPharmaceuticalRare diseases

US CMS ensures higher value and quality for Medicare health and drug plans

08-04-2014

The US Centers for Medicare & Medicaid Services (CMS) issued the 2015 rate announcement and final call…

FinancialHealthcareNorth AmericaPharmaceuticalUSA

UK Pharma moves on transparency of financial relationships with health professionals

03-04-2014

The UK’s pharmaceutical industry today announced another step towards greater transparency by revealing…

FinancialNorthern EuropePharmaceuticalResearchUK

Pernix to sell manufacturing facility to reduce costs

02-04-2014

US specialty pharma company Pernix Therapeutics has signed a definitive agreement to divest its Houston,…

FinancialPernix TherapeuticsPharmaceuticalProduction

GlaxoSmithKline targets strategic investments in Africa

02-04-2014

Speaking at the 5th EU-Africa Business Forum in Brussels this week, Sir Andrew Witty, chief executive…

FinancialGlaxoSmithKlineHealthcarePharmaceuticalRest of the WorldSouth Africa

Bayer Healthcare to invest 100 million euros to expand capacity in China

Bayer Healthcare to invest 100 million euros to expand capacity in China

31-03-2014

The HealthCare division of Germany’s Bayer will invest around 100 million euros ($137.5 million) to…

Asia-PacificBayerChinaFinancialPharmaceuticalProduction

Skyepharma posts 25% revenue growth for 2013

31-03-2014

UK-based Skyepharma, an oral and inhalation drug delivery company, today released financial results for…

FinancialPharmaceuticalSkyepharma

US FDA clears Biogen Idec and SOBI’s Alprolix for hemophilia B

US FDA clears Biogen Idec and SOBI’s Alprolix for hemophilia B

31-03-2014

Marking a second regulatory hurdle for the breakthrough product, the US Food and Drug Administration…

AlprolixBenefixBiogen IdecBiotechnologyCSL LimitedHematologyNorth AmericaNovo NordiskPfizerRegulationSwedish Orphan BiovitrumUSA

Philippine government increasing financial support for health care spending

28-03-2014

The size of the Philippine pharmaceutical market, now worth around $3.2 billion, is expected to expand…

Asia-PacificFinancialGenericsMarkets & MarketingPharmaceutical

1 to 25 of 1533 results

Back to top